Bridging critical gaps in advanced heart failure care
About 6.7 million American adults are living with heart failure (HF), and prevalence is expected to reach more than 8 million by 2030.[1] While there is no cure for HF,… read more.
About 6.7 million American adults are living with heart failure (HF), and prevalence is expected to reach more than 8 million by 2030.[1] While there is no cure for HF,… read more.
Can physical activity extend the lifespans of older adults? A review article published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.231336 summarizes the considerable evidence supporting the important role physical activity plays in… read more.
Roche announced that the FDA has granted 510(k) clearance and Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver for its cobas liat sexually transmitted infection (STI) multiplex assay… read more.
A new international study has unveiled critical insights in understanding post-traumatic epilepsy (PTE), a condition that can develop following traumatic brain injury. Led by researchers at FutureNeuro, the… read more.
More than one in three parents say their child has faced issues like tooth decay, cavities, stained teeth, gum concerns or tooth pain over the past two years,… read more.
Sobi will unveil new data at the annual European Association for Haemophilia and Allied Disorders (EAHAD 2025) congress in Milan from the 4th – 7th February, 2025. Outcomes… read more.
Nippon Shinyaku Co., Ltd. announced that it has obtained approval from the Ministry of Health, Labor and Welfare (MHLW) in Japan for Uptravi tablets 0.2 mg and 0.4… read more.
Two-thirds of people with post-COVID-19 syndrome have persistent, objective symptoms – including reduced physical exercise capacity and reduced cognitive test performances – for a year or more, with… read more.
Advances in technology have made it increasingly easier for people to self-monitor their heart health whether it’s via a smart device on their wrist or finger or a… read more.
Galderma announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting the marketing… read more.
A new study by researchers from the Brown University School of Public Health found that pregnant women are regularly excluded from clinical drug trials that test for safety, raising… read more.
The discovery and development of drugs in pharmacological research – including the risk assessment of active substances in the early phase of drug development – still largely relies… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.